Apollo Hospitals is set to introduce a new stem cell-based treatment for the cosmetic and reconstructive industry in India, in six months.
The new therapy — regenerative cell-based therapy — is the resurgence of autologous fat grafting and the emergence of cell-enriched fat grafting technique, where a patient's own fat (adipose) is derived as stem and regenerative cells (ADRCs) to be used for the treatment.
“We have already tested this celution system-based cell-enriched fat grafting cosmetic procedures in Hyderabad and Delhi as part of the initial evaluation technology,” said Dr Sudhakar Prasad, Apollo Hospitals.
The celution system-based cell-enriched fat grafting cosmetic procedure is a patented technique of US-based Cytory Therapeutics. This would be used for treatment of neurological problems, heart attacks, facial scars, facial rejuvenation and wound healing.
Hari Prasad, chief executive, Apollo Hospitals, said, “We are following the Centre's guidelines. We went through trials and are awaiting the scientific committee's outcome.”
The technique is being used on 3,000 patients globally. Here, the outcome is much faster as the segregation process takes 90 minutes and the entire treatment takes around six months, he said.
The Indian cosmetic industry is a multi-million industry. “This initiative would bring another revolution in the cosmetic and healthcare industry,” Prasad said.
Cytory has invested $300 million in research and development so far.
